LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 2,550 +25.00 (+0.99%) As of 08/29/2025 11:19 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Bioventix Stock (LON:BVXP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bioventix alerts:Sign Up Key Stats Today's Range 2,500▼ 2,55050-Day Range 2,300▼ 3,02052-Week Range 2,199▼ 4,359Volume5,554 shsAverage Volume7,416 shsMarket Capitalization£133.24 millionP/E Ratio1,721.58Dividend Yield0.06%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVXP Stock News HeadlinesDo Its Financials Have Any Role To Play In Driving Bioventix PLC's (LON:BVXP) Stock Up Recently?June 1, 2025 | finance.yahoo.comShareholders in Bioventix (LON:BVXP) are in the red if they invested a year agoMay 6, 2025 | finance.yahoo.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 30 at 2:00 AM | Brownstone Research (Ad)5 AIM stocks to consider buying for the long termApril 24, 2025 | msn.com3 UK Dividend Stocks Offering Yields Up To 7.2%April 8, 2025 | finance.yahoo.com3 top AIM stocks to consider buying before they recoverMarch 19, 2025 | uk.finance.yahoo.comWith 62% ownership, Bioventix PLC (LON:BVXP) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comWill the stock market rise in 2025, and how high could it go?December 14, 2024 | msn.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 3,240 at the start of the year. Since then, BVXP stock has decreased by 21.3% and is now trading at GBX 2,550. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) announced its quarterly earnings data on Monday, March, 31st. The biotechnology company reported $72.27 EPS for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/31/2025Today8/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 1.48 Trailing P/E Ratio1,721.58 Forward P/E Ratio15.33 P/E GrowthN/ANet Income£8.12 million Net Margins59.51% Pretax MarginN/A Return on Equity69.09% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio5.50 Sales & Book Value Annual Sales£13.66 million Price / Sales9.75 Cash FlowGBX 82.56 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book11.09Miscellaneous Outstanding Shares5,225,000Free FloatN/AMarket Cap£133.24 million OptionableNot Optionable Beta0.35 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (LON:BVXP) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
